You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

PRALIDOXIME CHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for pralidoxime chloride and what is the scope of freedom to operate?

Pralidoxime chloride is the generic ingredient in three branded drugs marketed by Baxter Hlthcare Corp, Meridian Medcl Techn, and Wyeth Ayerst, and is included in four NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for pralidoxime chloride. One supplier is listed for this compound.

Summary for PRALIDOXIME CHLORIDE
US Patents:0
Tradenames:3
Applicants:3
NDAs:4
Drug Master File Entries: 5
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 116
Patent Applications: 1,450
What excipients (inactive ingredients) are in PRALIDOXIME CHLORIDE?PRALIDOXIME CHLORIDE excipients list
DailyMed Link:PRALIDOXIME CHLORIDE at DailyMed
Pharmacology for PRALIDOXIME CHLORIDE

US Patents and Regulatory Information for PRALIDOXIME CHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare Corp PRALIDOXIME CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 018799-001 Dec 13, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Wyeth Ayerst PROTOPAM CHLORIDE pralidoxime chloride TABLET;ORAL 014122-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Baxter Hlthcare Corp PROTOPAM CHLORIDE pralidoxime chloride INJECTABLE;INJECTION 014134-001 Approved Prior to Jan 1, 1982 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Meridian Medcl Techn PRALIDOXIME CHLORIDE (AUTOINJECTOR) pralidoxime chloride SOLUTION;INTRAMUSCULAR 018986-001 Apr 26, 1983 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.